col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Molecules
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―21 Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective J. Carlos Menéndez
2 [GO] 2022―Jan―19 Colorimetric and Electrochemical Methods for the Detection of SARS-CoV-2 Main Protease by Peptide-Triggered Assembly of Gold Nanoparticles Yunxiao Feng, Gang Liu, Ming La, Lin Liu
3 [GO] 2022―Jan―18 Nucleotide Analogues Bearing a C2′ or C3′-Stereogenic All-Carbon Quaternary Center as SARS-CoV-2 RdRp Inhibitors Amarender Manchoju, Renaud Zelli, Gang Wang, Carla Eymard, Adrian Oo, Mona Nemer, et al. (+3)
4 [GO] 2022―Jan―14 Can Artemisia herba-alba Be Useful for Managing COVID-19 and Comorbidities? Anamul Hasan, Partha Biswas, Tohmina Afroze Bondhon, Khoshnur Jannat, Tridib K. Paul, Alok K. Paul, et al. (+8)
5 [GO] 2022―Jan―14 Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study Sraa Abu-Melha, Mastoura Mohamed Edrees, Musa A. Said, Sayed M. Riyadh, Nadia S. Al-Kaff, Sobhi M. Gomha
6 [GO] 2022―Jan―07 Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach Trina Ekawati Tallei, Ahmad Akroman Adam, Mona M. Elseehy, Ahmed M. El-Shehawi, Eman A. Mahmoud, Adinda Dwi Tania, et al. (+8)
7 [GO] 2022―Jan―07 Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses Vladislav V. Fomenko, Nadezhda B. Rudometova, Olga I. Yarovaya, Artem D. Rogachev, Anastasia A. Fando, Anna V. Zaykovskaya, et al. (+7)
8 [GO] 2021―Dec―31 Computational Study of SARS-CoV-2 RNA Dependent RNA Polymerase Allosteric Site Inhibition Shah Faisal, Syed Lal Badshah, Bibi Kubra, Mohamed Sharaf, Abdul-Hamid Emwas, Mariusz Jaremko, Mohnad Abdalla
9 [GO] 2021―Dec―27 Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome Magdalena Świądro, Klaudia Ordon, Małgorzata Herman, Dominika Dudek, Renata Wietecha-Posłuszny
10 [GO] 2021―Dec―16 A Dispersion Corrected DFT Investigation of the Inclusion Complexation of Dexamethasone with β-Cyclodextrin and Molecular Docking Study of Its Potential Activity against COVID-19 Youghourta Belhocine, Seyfeddine Rahali, Hamza Allal, Ibtissem Meriem Assaba, Monira Galal Ghoniem, Fatima Adam Mohamed Ali
11 [GO] 2021―Dec―10 Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment Amin Osman Elzupir
12 [GO] 2021―Dec―10 Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
13 [GO] 2021―Dec―09 Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp) Yifei Wu, David Crich, Scott D. Pegan, Lei Lou, Madelyn C. Hansen, Carson Booth, et al. (+5)
14 [GO] 2021―Dec―06 Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design Wei Yu, Xiaomin Wu, Yizhen Zhao, Chun Chen, Zhiwei Yang, Xiaochun Zhang, et al. (+9)
15 [GO] 2021―Dec―01 Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review Md Sultan Mahmud, Mohammad Sorowar Hossain, A. T. M. Faiz Ahmed, Md Zahidul Islam, Md Emdad Sarker, Md Reajul Islam
16 [GO] 2021―Nov―18 The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19 George El-Arif, Antonella Farhat, Shaymaa Khazaal, Cédric Annweiler, Hervé Kovacic, Yingliang Wu, et al. (+4)
17 [GO] 2021―Nov―18 Ultrasensitive Detection of COVID-19 Causative Virus (SARS-CoV-2) Spike Protein Using Laser Induced Graphene Field-Effect Transistor Tian-Rui Cui, Yan-Cong Qiao, Jian-Wei Gao, Chun-Hua Wang, Yu Zhang, Lin Han, et al. (+2)
18 [GO] 2021―Nov―17 Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, Lizdany Flórez-Álvarez, Lina M. Yepes, Maria T. Rugeles, et al. (+3)
19 [GO] 2021―Nov―12 Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63 Monika Horvat, Martina Avbelj, María Beatriz Durán-Alonso, Mihailo Banjanac, Hrvoje Petković, Jernej Iskra
20 [GO] 2021―Nov―10 Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions Priyanka Saha, Subhankar Bose, Amit Kumar Srivastava, Anis Ahmad Chaudhary, Rajiv Lall, Sahdeo Prasad
21 [GO] 2021―Nov―09 Characterization of the Trans-Epithelial Transport of Green Tea (C. sinensis) Catechin Extracts with In Vitro Inhibitory Effect against the SARS-CoV-2 Papain-like Protease Activity Carmela Maria Montone, Sara Elsa Aita, Anna Arnoldi, Anna Laura Capriotti, Chiara Cavaliere, Andrea Cerrato, et al. (+4)
22 [GO] 2021―Nov―02 Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury Pierpaolo Coni, Giuseppina Pichiri, Joanna Izabela Lachowicz, Alberto Ravarino, Francesca Ledda, Daniela Fanni, et al. (+10)
23 [GO] 2021―Nov―02 Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2 Ahmed A. Al-Karmalawy, Mai M. Farid, Ahmed Mostafa, Alia Y. Ragheb, Sara H. Mahmoud, Mahmoud Shehata, et al. (+4)
24 [GO] 2021―Nov―02 Robust Saliva-Based RNA Extraction-Free One-Step Nucleic Acid Amplification Test for Mass SARS-CoV-2 Monitoring Eva Rajh, Tina Šket, Arne Praznik, Petra Sušjan, Alenka Šmid, Dunja Urbančič, et al. (+12)
25 [GO] 2021―Nov―02 In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies Mohamed S. Alesawy, Eslam B. Elkaeed, Aisha A. Alsfouk, Ahmed M. Metwaly, Ibrahim H. Eissa
26 [GO] 2021―Oct―27 A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses Aaya Nassar, Ibrahim M. Ibrahim, Fatma G. Amin, Merna Magdy, Ahmed M. Elgharib, Eman B. Azzam, et al. (+5)
27 [GO] 2021―Oct―15 In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease Vishma Pratap Sur, Madhab Kumar Sen, Katerina Komrskova
28 [GO] 2021―Oct―15 Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages Ken Shirato, Jun Takanari, Takako Kizaki
29 [GO] 2021―Oct―14 Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2 Amr El-Demerdash, Afnan Hassan, Tarek Mohamed Abd Abd El-Aziz, James D. Stockand, Reem K. Arafa
30 [GO] 2021―Oct―14 In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine Mahmoud M. Shehata, Sara H. Mahmoud, Mohammad Tarek, Ahmed A. Al-Karmalawy, Amal Mahmoud, Ahmed Mostafa, et al. (+2)
31 [GO] 2021―Oct―13 In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10 Ibrahim H. Eissa, Mohamed M. Khalifa, Eslam B. Elkaeed, Elsayed E. Hafez, Aisha A. Alsfouk, Ahmed M. Metwaly
32 [GO] 2021―Oct―11 Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment Jingjing Li, Dongge Xu, Lingling Wang, Mengyu Zhang, Guohai Zhang, Erguang Li, Susu He
33 [GO] 2021―Oct―09 Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury Lúcio Ricardo Leite Diniz, Hatem A. Elshabrawy, Marilia Trindade de Santana Souza, Allana Brunna Sucupira Duarte, Sabarno Datta, Damião Pergentino de Sousa
34 [GO] 2021―Oct―09 Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs Athanasios A. Panagiotopoulos, Ioannis Karakasiliotis, Danai-Maria Kotzampasi, Marios Dimitriou, George Sourvinos, Marilena Kampa, et al. (+3)
35 [GO] 2021―Oct―09 l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells Luca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, et al. (+10)
36 [GO] 2021―Sep―28 Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19 Mohd. Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Saleh I. Alaqel, Mohammed Kanan Alshammari, et al. (+8)
37 [GO] 2021―Sep―28 Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19 Roberta Bernini, Francesca Velotti
38 [GO] 2021―Sep―28 Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors Arun K. Ghosh, Dana Shahabi, Monika Yadav, Satish Kovela, Brandon J. Anson, Emma K. Lendy, et al. (+7)
39 [GO] 2021―Sep―22 In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2 Seyyed Sasan Mousavi, Akbar Karami, Tahereh Movahhed Haghighi, Sefren Geiner Tumilaar, Rinaldi Idroes, Shafi Mahmud, et al. (+5)
40 [GO] 2021―Sep―13 The Influence of Propolis on Dental Plaque Reduction and the Correlation between Dental Plaque and Severity of COVID-19 Complications-A Literature Review Anna Kurek-Górecka, Karolina Walczyńska-Dragon, Rafael Felitti, Aleksandra Nitecka-Buchta, Stefan Baron, Paweł Olczyk
41 [GO] 2021―Sep―08 Inactivation Activities of Ozonated Water, Slightly Acidic Electrolyzed Water and Ethanol against SARS-CoV-2 Yohei Takeda, Dulamjav Jamsransuren, Yoshimasa Makita, Akihiro Kaneko, Sachiko Matsuda, Haruko Ogawa, Hourei Oh
42 [GO] 2021―Sep―07 A Review of the Health Protective Effects of Phenolic Acids against a Range of Severe Pathologic Conditions (Including Coronavirus-Based Infections) Sotirios Kiokias, Vassiliki Oreopoulou
43 [GO] 2021―Aug―31 GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Zingiber officinale Roscoe Muhammad Sulaiman Zubair, Saipul Maulana, Agustinus Widodo, Ramadanil Pitopang, Muhammad Arba, Maywan Hariono
44 [GO] 2021―Aug―25 Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations Devashan Naidoo, Pallab Kar, Ayan Roy, Taurai Mutanda, Joseph Bwapwa, Arnab Sen, Akash Anandraj
45 [GO] 2021―Aug―18 An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations Amin Islam, Mohammed Sheraz Bashir, Kevin Joyce, Harunor Rashid, Ismail Laher, Shereen Elshazly
46 [GO] 2021―Aug―18 Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD Thamer A. Bouback, Sushil Pokhrel, Abdulaziz Albeshri, Amal Mohammed Aljohani, Abdus Samad, Rahat Alam, et al. (+6)
47 [GO] 2021―Aug―12 Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors Marjorie C. L. C. Freire, Gabriela D. Noske, Natália V. Bitencourt, Paulo R. S. Sanches, Norival A. Santos-Filho, Victor O. Gawriljuk, et al. (+14)
48 [GO] 2021―Aug―09 Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins Yohei Takeda, Kyohei Tamura, Dulamjav Jamsransuren, Sachiko Matsuda, Haruko Ogawa
49 [GO] 2021―Jul―06 Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2 Susana A. Llivisaca-Contreras, Jaime Naranjo-Morán, Andrea Pino-Acosta, Luc Pieters, Wim Vanden Berghe, Patricia Manzano, et al. (+3)
50 [GO] 2021―Jun―29 Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19 Ying-Qi Wang, Qing-Sheng Li, Xin-Qiang Zheng, Jian-Liang Lu, Yue-Rong Liang
51 [GO] 2021―Jun―28 Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review Mohammad Amin Khazeei Tabari, Amin Iranpanah, Roodabeh Bahramsoltani, Roja Rahimi
52 [GO] 2021―Jun―28 Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes Nadezhda Palko, Maria Grishina, Vladimir Potemkin
53 [GO] 2021―Jun―25 Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach Luis Daniel Goyzueta-Mamani, Haruna Luz Barazorda-Ccahuana, Karel Mena-Ulecia, Miguel Angel Chávez-Fumagalli
54 [GO] 2021―Jun―24 A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov Rambod Abiri, Hazandy Abdul-Hamid, Oksana Sytar, Ramin Abiri, Eduardo Bezerra de Almeida, Surender K. Sharma, et al. (+3)
55 [GO] 2021―Jun―23 Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma Mohammad Hailat, Israa Al-Ani, Mohammed Hamad, Zainab Zakareia, Wael Abu Dayyih
56 [GO] 2021―Jun―21 Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization Ayman Abo Elmaaty, Mohammed I. A. Hamed, Muhammad I. Ismail, Eslam B. Elkaeed, Hamada S. Abulkhair, Muhammad Khattab, Ahmed A. Al-Karmalawy
57 [GO] 2021―Jun―21 Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study Nourhan Hisham Shady, Alaa M. Hayallah, Mamdouh F. A. Mohamed, Mohammed M. Ghoneim, Garri Chilingaryan, Mohammad M. Al-Sanea, et al. (+3)
58 [GO] 2021―Jun―11 Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins Eriko Ohgitani, Masaharu Shin-Ya, Masaki Ichitani, Makoto Kobayashi, Takanobu Takihara, Masaya Kawamoto, et al. (+2)
59 [GO] 2021―Jun―09 A Multidisciplinary Approach to Coronavirus Disease (COVID-19) Aliye Gediz Gediz Erturk, Arzu Sahin, Ebru Bati Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, et al. (+5)
60 [GO] 2021―Jun―09 Transport of Aerosols in Underground Mine Workings in Terms of SARS-CoV-2 Virus Threat Krystian Skubacz, Robert Hildebrandt, Aleksandra Zgórska, Zdzisław Dyduch, Krzysztof Samolej, Adam Smolinski
61 [GO] 2021―Jun―07 Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-CoV-2 Denis O. Shatalov, Stanislav A. Kedik, Ivan S. Ivanov, Anna V. Aydakova, Diana A. Akhmedova, Dmitrii S. Minenkov, et al. (+5)
62 [GO] 2021―Jun―07 Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues Vasiliki Daikopoulou, Panagiotis Apostolou, Sofia Mourati, Ioanna Vlachou, Maria Gougousi, Ioannis Papasotiriou
63 [GO] 2021―Jun―02 Anti-Inflammatory, Antiallergic, and COVID-19 Main Protease (Mpro) Inhibitory Activities of Butenolides from a Marine-Derived Fungus Aspergillus terreus Ibrahim Seyda Uras, Sherif S. Ebada, Michal Korinek, Amgad Albohy, Basma S. Abdulrazik, Yi-Hsuan Wang, et al. (+5)
64 [GO] 2021―May―27 Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries Alon Ben David, Eran Diamant, Eyal Dor, Ada Barnea, Niva Natan, Lilach Levin, et al. (+5)
65 [GO] 2021―May―18 Prioritisation of Compounds for 3CLpro Inhibitor Development on SARS-CoV-2 Variants Marko Jukič, Blaž Škrlj, Gašper Tomšič, Sebastian Pleško, Črtomir Podlipnik, Urban Bren
66 [GO] 2021―May―14 Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates Sajad Fakhri, Zeinab Nouri, Seyed Zachariah Moradi, Esra Küpeli Akkol, Sana Piri, Eduardo Sobarzo-Sánchez, et al. (+2)
67 [GO] 2021―May―11 Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability Nikola Gligorijević, Dragana Stanić-Vučinić, Mirjana Radomirović, Marija Stojadinović, Urmila Khulal, Olgica Nedić, Tanja Ćirković Veličković
68 [GO] 2021―May―10 In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Mohamed S. Alesawy, Abdallah E. Abdallah, Mohammed S. Taghour, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly
69 [GO] 2021―Apr―30 The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19 Tatyana A. Kuznetsova, Boris G. Andryukov, Ilona D. Makarenkova, Tatyana S. Zaporozhets, Natalya N. Besednova, Ludmila N. Fedyanina, et al. (+2)
70 [GO] 2021―Apr―30 Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis Federico Vittorio Rossi, Dario Gentili, Enrico Marcantoni
71 [GO] 2021―Apr―30 D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect Romina Oliva, Abdul Rajjak Shaikh, Andrea Petta, Anna Vangone, Luigi Cavallo
72 [GO] 2021―Apr―29 Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, Dominika Chalupska, Jana Humpolickova, Evžen Bouřa, et al. (+10)
73 [GO] 2021―Apr―29 In Vitro Inhibitory Analysis of Rationally Designed siRNAs against MERS-CoV Replication in Huh7 Cells Sherif Aly El-Kafrawy, Sayed Sartaj Sohrab, Zeenat Mirza, Ahmed M. Hassan, Fatima Alsaqaf, Esam Ibraheem Azhar
74 [GO] 2021―Apr―20 An Effective MM/GBSA Protocol for Absolute Binding Free Energy Calculations: A Case Study on SARS-CoV-2 Spike Protein and the Human ACE2 Receptor Negin Forouzesh, Nikita Mishra
75 [GO] 2021―Apr―12 Molecular Dynamic Simulation Search for Possible Amphiphilic Drug Discovery for Covid-19 Umer Daood, Divya Gopinath, Malikarjuna Rao Pichika, Kit-Kay Mak, Liang Lin Seow
76 [GO] 2021―Apr―12 Efficacy of Phytochemicals Derived from Avicennia officinalis for the Management of COVID-19: A Combined In Silico and Biochemical Study Shafi Mahmud, Gobindo Kumar Paul, Mirola Afroze, Shirmin Islam, Swagota Briti Ray Gupt, Mamudul Hasan Razu, et al. (+9)
77 [GO] 2021―Apr―09 Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2 Md. Asraful Alam, Roberto Parra-Saldivar, Muhammad Bilal, Chowdhury Alfi Afroze, Md. Nasir Ahmed, Hafiz M.N. Iqbal, Jingliang Xu
78 [GO] 2021―Apr―09 Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor Norbert Odolczyk, Ewa Marzec, Maria Winiewska-Szajewska, Jarosław Poznański, Piotr Zielenkiewicz
79 [GO] 2021―Apr―05 In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Tarik A. Mohamed, Mohamed A. M. Atia, Montaser A. M. Al-Hammady, Khlood A. A. Abdeljawaad, et al. (+8)
80 [GO] 2021―Mar―30 The Inhibitory Effects of Plant Derivate Polyphenols on the Main Protease of SARS Coronavirus 2 and Their Structure-Activity Relationship Thi Thanh Hanh Nguyen, Jong-Hyun Jung, Min-Kyu Kim, Sangyong Lim, Jae-Myoung Choi, Byoungsang Chung, et al. (+2)
81 [GO] 2021―Mar―29 Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform Kaushik Chakravarty, Victor G. Antontsev, Maksim Khotimchenko, Nilesh Gupta, Aditya Jagarapu, Yogesh Bundey, et al. (+3)
82 [GO] 2021―Mar―22 Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities Salar Hafez Ghoran, Mohamed El-Shazly, Nazim Sekeroglu, Anake Kijjoa
83 [GO] 2021―Mar―22 Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2 Arumugam Vijaya Anand, Balasubramanian Balamuralikrishnan, Mohandass Kaviya, Kathirvel Bharathi, Aluru Parithathvi, Meyyazhagan Arun, et al. (+8)
84 [GO] 2021―Mar―22 Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development Mohamed E. Abouelela, Hamdy K. Assaf, Reda A. Abdelhamid, Ehab S. Elkhyat, Ahmed M. Sayed, Tomasz Oszako, et al. (+3)
85 [GO] 2021―Mar―12 Receptor-Based Pharmacophore Modeling in the Search for Natural Products for Covid-19 Mpro Mohd Saeed, Amir Saeed, Md. Jahoor Alam, Mousa Alreshidi
86 [GO] 2021―Mar―08 Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme Sajjad Ahmad, Yasir Waheed, Saba Ismail, Saadia Bhatti, Sumra Wajid Abbasi, Khalid Muhammad
87 [GO] 2021―Mar―05 SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome Anna Maria Sardanelli, Camilla Isgrò, Luigi Leonardo Palese
88 [GO] 2021―Feb―26 Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies Amira Mohammed Ali, Hiroshi Kunugi
89 [GO] 2021―Feb―24 EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection Mukesh Chourasia, Purushotham Reddy Koppula, Aruna Battu, Madhu M. Ouseph, Anil K. Singh
90 [GO] 2021―Feb―23 Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach Christian R. Gomez, Ingrid Espinoza, Fazlay S. Faruke, Md. Mahbub Hasan, Khondaker Miraz Rahman, Larry A. Walker, Ilias Muhammad
91 [GO] 2021―Feb―22 Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease Roxanna Hajbabaie, Matthew T. Harper, Taufiq Rahman
92 [GO] 2021―Feb―19 In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2 Sebastián A. Cuesta, José R. Mora, Edgar A. Márquez
93 [GO] 2021―Feb―14 Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders Roberta Giordo, Angelo Zinellu, Ali Hussein Eid, Gianfranco Pintus
94 [GO] 2021―Feb―14 Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses Nicola Borbone, Gennaro Piccialli, Giovanni Nicola Roviello, Giorgia Oliviero
95 [GO] 2021―Feb―12 Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors Poonam Kalhotra, Veera C.S.R. Chittepu, Guillermo Osorio-Revilla, Tzayhri Gallardo-Velazquez
96 [GO] 2021―Feb―04 Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease Candida Manelfi, Jonas Gossen, Silvia Gervasoni, Carmine Talarico, Simone Albani, Benjamin Joseph Philipp, et al. (+5)
97 [GO] 2021―Jan―31 COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds Oksana Sytar, Marian Brestic, Shokoofeh Hajihashemi, Milan Skalicky, Jan Kubeš, Laura Lamilla-Tamayo, et al. (+3)
98 [GO] 2021―Jan―30 In Silico Study of Polyunsaturated Fatty Acids as Potential SARS-CoV-2 Spike Protein Closed Conformation Stabilizers: Epidemiological and Computational Approaches Alonso Vivar-Sierra, María José Araiza-Macías, José Patricio Hernández-Contreras, Arely Vergara-Castañeda, Gabriela Ramírez-Vélez, Rodolfo Pinto-Almazán, et al. (+2)
99 [GO] 2021―Jan―28 Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism Riadh Badraoui, Mohd Adnan, Fevzi Bardakci, Mousa M. Alreshidi
100 [GO] 2021―Jan―28 Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2 Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad, Guanglin Li
101 [GO] 2021―Jan―26 Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets Isabella Romeo, Francesco Mesiti, Antonio Lupia, Stefano Alcaro
102 [GO] 2021―Jan―25 From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy John Matsoukas, Vasso Apostolopoulos, Anthony Zulli, Graham Moore, Konstantinos Kelaidonis, Kalliopi Moschovou, Thomas Mavromoustakos
103 [GO] 2021―Jan―19 Natural and Nature-Derived Products Targeting Human Coronaviruses Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Michael N. Alexis, Alexios-Leandros Skaltsounis
104 [GO] 2020―Dec―31 The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities Xiao Cong Pang, Han Xu Zhang, Zhi Zhang, Suguro Rinkiko, Yi Min Cui, Yi Zhun Zhu
105 [GO] 2020―Dec―29 Nicotine Changes Airway Epithelial Phenotype and May Increase the SARS-COV-2 Infection Severity Leonardo Lupacchini, Fabrizio Maggi, Carlo Tomino, Chiara De Dominicis, Cristiana Mollinari, Massimo Fini, et al. (+3)
106 [GO] 2020―Dec―25 Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology Zhi-Ling Zhu, Xiao-Dan Qiu, Shuo Wu, Yi-Tong Liu, Ting Zhao, Zhong-Hao Sun, et al. (+2)
107 [GO] 2020―Dec―23 COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far Mujeeb Khan, Syed F. Adil, Hamad Z. Alkhathlan, Muhammad N. Tahir, Sadia Saif, Merajuddin Khan, Shams T. Khan
108 [GO] 2020―Dec―23 Anomaly Identification during Polymerase Chain Reaction for Detecting SARS-CoV-2 Using Artificial Intelligence Trained from Simulated Data Reynaldo Villarreal-González, Antonio J. Acosta-Hoyos, Jaime A. Garzon-Ochoa, Nataly J. Galán-Freyle, Paola Amar-Sepúlveda, Leonardo C. Pacheco-Londoño
109 [GO] 2020―Dec―17 Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment Bwalya A. Witika, Pedzisai A. Makoni, Larry L. Mweetwa, Pascal V. Ntemi, Melissa T. R. Chikukwa, Scott K. Matafwali, et al. (+4)
110 [GO] 2020―Dec―15 Pandemic-Driven Development of a Medical-Grade, Economic and Decentralized Applicable Polyolefin Filament for Additive Fused Filament Fabrication Felix Burkhardt, Carl G. Schirmeister, Christian Wesemann, Massimo Nutini, Stefano Pieralli, Erik H. Licht, et al. (+4)
111 [GO] 2020―Dec―14 Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction Mohammed Sikander, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, et al. (+3)
112 [GO] 2020―Dec―14 Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? Giovanna Giovinazzo, Carmela Gerardi, Caterina Uberti-Foppa, Lucia Lopalco
113 [GO] 2020―Dec―14 Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features Sk. Sarif Hassan, Shinjini Ghosh, Diksha Attrish, Pabitra Pal Choudhury, Alaa A. A. Aljabali, Bruce D. Uhal, et al. (+18)
114 [GO] 2020―Dec―11 The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients Alessandro G. Fois, Panagiotis Paliogiannis, Valentina Scano, Stefania Cau, Sergio Babudieri, Roberto Perra, et al. (+9)
115 [GO] 2020―Dec―11 Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury Lúcio Ricardo Leite Diniz, Marilia Trindade de Santana Souza, Allana Brunna Sucupira Duarte, Damião Pergentino de Sousa
116 [GO] 2020―Dec―11 Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CLpro) Non-Covalent Small-Molecule Inhibitors Marko Jukič, Dušanka Janežič, Urban Bren
117 [GO] 2020―Dec―11 Molecular Docking Study on Several Benzoic Acid Derivatives against SARS-CoV-2 Amalia Stefaniu, Lucia Pirvu, Bujor Albu, Lucia Pintilie
118 [GO] 2020―Dec―02 Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach Mohd Saeed, Amir Saeed, Md Jahoor Alam, Mousa Alreshidi
119 [GO] 2020―Nov―30 Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein Loai M. Saadah, Ghina’a I. Abu Deiab, Qosay Al-Balas, Iman A. Basheti
120 [GO] 2020―Nov―30 Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study Gema Lizbeth Ramírez-Salinas, Marlet Martínez-Archundia, José Correa-Basurto, Jazmín García-Machorro
121 [GO] 2020―Nov―26 In Silico Discovery of Antimicrobial Peptides as an Alternative to Control SARS-CoV-2 Yamil Liscano, Jose Oñate-Garzón, Iván Darío Ocampo-Ibáñez
122 [GO] 2020―Nov―24 Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach Teresa L. Augustin, Roxanna Hajbabaie, Matthew T. Harper, Taufiq Rahman
123 [GO] 2020―Nov―24 Alkaloids: Therapeutic Potential against Human Coronaviruses Burtram C. Fielding, Carlos da Silva Maia Bezerra Filho, Nasser S. M. Ismail, Damião Pergentino de Sousa
124 [GO] 2020―Nov―18 A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2 Cecy R Xi, Arianna Di Fazio, Naveed Ahmed Nadvi, Karishma Patel, Michelle Sui Wen Xiang, Hui Emma Zhang, et al. (+12)
125 [GO] 2020―Nov―17 The Role of Vitamin C, Vitamin D, and Selenium in Immune System against COVID-19 Minkyung Bae, Hyeyoung Kim
126 [GO] 2020―Nov―09 Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease Eduardo Tejera, Cristian R. Munteanu, Andrés López-Cortés, Alejandro Cabrera-Andrade, Yunierkis Pérez-Castillo
127 [GO] 2020―Nov―03 Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation Acharya Balkrishna, Siva Kumar Solleti, Sudeep Verma, Anurag Varshney
128 [GO] 2020―Nov―03 Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2 Ahmed Rakib, Saad Ahmed Sami, Md. Ashiqul Islam, Shahriar Ahmed, Farhana Binta Faiz, Bibi Humayra Khanam, et al. (+6)
129 [GO] 2020―Nov―01 In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2 Mathieu Gendrot, Julien Andreani, Priscilla Jardot, Sébastien Hutter, Océane Delandre, Manon Boxberger, et al. (+8)
130 [GO] 2020―Oct―30 Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Kamran Sattar, Suhana Ahmad, Mohd Zulkifli Mustafa, Marcelo De Carvalho Bittencourt, Rohimah Mohamud
131 [GO] 2020―Oct―30 Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies Safaa M. Kishk, Rania M. Kishk, Asmaa S. A. Yassen, Mohamed S. Nafie, Nader A. Nemr, Gamal ElMasry, et al. (+2)
132 [GO] 2020―Oct―17 Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives Camilo Zamora-Ledezma, David F. Clavijo C., Ernesto Medina, Federico Sinche, Nelson Santiago Vispo, Si Amar Dahoumane, Frank Alexis
133 [GO] 2020―Oct―17 High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor Alistair S. Brown, David F. Ackerley, Mark J. Calcott
134 [GO] 2020―Oct―17 Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein-Human ACE2 Receptor Interface Wojciech Płonka, Agata Paneth, Piotr Paneth
135 [GO] 2020―Oct―17 Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study Rajveer Singh, Anupam Gautam, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Syamal Roy, et al. (+2)
136 [GO] 2020―Oct―07 Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro) Sraa Abu-Melha, Mastoura M. Edrees, Sayed M. Riyadh, Mohamad R. Abdelaziz, Abdo A. Elfiky, Sobhi M. Gomha
137 [GO] 2020―Sep―25 Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19 Dun-Xian Tan, Ruediger Hardeland
138 [GO] 2020―Sep―24 Peptides: Prospects for Use in the Treatment of COVID-19 Vladimir Khavinson, Natalia Linkova, Anastasiia Dyatlova, Boris Kuznik, Roman Umnov
139 [GO] 2020―Sep―11 Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction Danuta Witkowska
140 [GO] 2020―Sep―08 Polyphenols vs. Coronaviruses: How Far Has Research Moved Forward? Simona Piccolella, Giuseppina Crescente, Shadab Faramarzi, Marialuisa Formato, Maria Tommasina Pecoraro, Severina Pacifico
141 [GO] 2020―Sep―07 The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents Gustavo R. Villas-Boas, Vanessa C. Rescia, Marina M. Paes, Stefânia N. Lavorato, Manoel F. de Magalhães-Filho, Mila S. Cunha, et al. (+21)
142 [GO] 2020―Aug―28 Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19 Ahmed Rakib, Arkajyoti Paul, Md. Nazim Uddin Chy, Saad Ahmed Sami, Sumit Kumar Baral, Mohuya Majumder, et al. (+8)
143 [GO] 2020―Aug―24 In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection R.P. Vivek-Ananth, Abhijit Rana, Nithin Rajan, Himansu S. Biswal, Areejit Samal
144 [GO] 2020―Aug―24 Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method Milan Sencanski, Vladimir Perovic, Snezana B. Pajovic, Miroslav Adzic, Slobodan Paessler, Sanja Glisic
145 [GO] 2020―Aug―17 Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study Stefania Mazzini, Loana Musso, Sabrina Dallavalle, Roberto Artali
146 [GO] 2020―Jul―30 Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections Daniel P. Otto, Melgardt M. de Villiers
147 [GO] 2020―Jul―22 High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2 Olujide O. Olubiyi, Maryam Olagunju, Monika Keutmann, Jennifer Loschwitz, Birgit Strodel
148 [GO] 2020―Jun―30 Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1 Olga Tarasova, Sergey Ivanov, Dmitry A. Filimonov, Vladimir Poroikov
149 [GO] 2020―Jun―16 Potential of Flavonoid-Inspired Phytomedicines against COVID-19 Wilfred Ngwa, Rajiv Kumar, Daryl Thompson, William Lyerly, Roscoe Moore, Terry-Elinor Reid, et al. (+2)
150 [GO] 2020―Jun―03 In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus Phaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou, Athina Geronikaki
151 [GO] 2020―May―22 Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming Elisa Barile, Carlo Baggio, Luca Gambini, Sergey A. Shiryaev, Alex Y. Strongin and Maurizio Pellecchia
152 [GO] 2020―May―20 Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E) Keykavous Parang, Naglaa Salem El-Sayed, Assad J. Kazeminy, Rakesh K. Tiwari
153 [GO] 2020―May―12 Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2) Noor Rahman, Zarrin Basharat, Muhammad Yousuf, Giuseppe Castaldo, Luca Rastrelli, Haroon Khan
154 [GO] 2020―Apr―29 Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease Carmen Ciavarella, Ilenia Motta, Sabrina Valente, Gianandrea Pasquinelli
155 [GO] 2020―Apr―21 Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight Inès Thabti, Quentin Albert, Stéphanie Philippot, François Dupire, Brenda Westerhuis, Stéphane Fontanay, et al. (+5)
156 [GO] 2020―Apr―16 COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help Giovanni Lentini, Maria Maddalena Cavalluzzi, Solomon Habtemariam
157 [GO] 2020―Apr―15 Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses Nakarin Suwannarach, Jaturong Kumla, Kanaporn Sujarit, Thanawat Pattananandecha, Chalermpong Saenjum, Saisamorn Lumyong


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.017 sec